Indirect monitoring of ultralow dose API content in continuous wet granulation and tableting by machine vision

Int J Pharm. 2021 Sep 25:607:121008. doi: 10.1016/j.ijpharm.2021.121008. Epub 2021 Aug 13.

Abstract

This paper presents new machine vision-based methods for indirect real-time quantification of ultralow drug content during continuous twin-screw wet granulation and tableting. Granulation was performed with a solution containing carvedilol (CAR) as API in the ultralow dose range (0.05w/w% in the granule) and the addition of riboflavin (RI) as a coloured tracer. An in-line calibration in the range of 0.047-0.058 w/w% was prepared for the measurement of CAR concentration using colour analysis (CA) and particle size analysis (PSA), and the validation with HPLC resulted in respective relative errors of 2.62% and 2.30% showing great accuracy. To improve the technique, a second in-line calibration was conducted in a broader CAR concentration range of 0.039-0.063 w/w% utilizing only half the amount of RI (0.045 w/w%), while doubling the output of the granulation line to 2 kg/h, producing a relative error of 4.51% and 4.29%, respectively. Finally, it was shown that the CA technique can also be carried on to monitor the CAR content of tablets in the 42-62 μg dose range with a relative error of 5.20%. Machine vision was proven to be a potent indirect method for the in-line, determination and monitoring of ultralow API content during continuous manufacturing.

Keywords: API content measurement; Coloured tracer; Continuous twin-screw wet granulation; Machine vision; PAT; Particle size analysis; Ultralow dose.

MeSH terms

  • Calibration
  • Drug Compounding*
  • Particle Size
  • Tablets
  • Technology, Pharmaceutical*

Substances

  • Tablets